Courier Capital LLC lowered its holdings in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 44.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,522 shares of the company’s stock after selling 1,218 shares during the quarter. Courier Capital LLC’s holdings in Zoetis were worth $248,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Cherry Creek Investment Advisors Inc. grew its holdings in shares of Zoetis by 2.0% in the third quarter. Cherry Creek Investment Advisors Inc. now owns 3,021 shares of the company’s stock valued at $590,000 after purchasing an additional 58 shares in the last quarter. Grove Bank & Trust lifted its position in Zoetis by 0.5% during the third quarter. Grove Bank & Trust now owns 11,763 shares of the company’s stock valued at $2,298,000 after purchasing an additional 61 shares during the last quarter. Hancock Whitney Corp grew its stake in shares of Zoetis by 0.3% in the 3rd quarter. Hancock Whitney Corp now owns 18,569 shares of the company’s stock worth $3,628,000 after buying an additional 61 shares in the last quarter. Strategy Asset Managers LLC increased its holdings in shares of Zoetis by 3.5% in the 3rd quarter. Strategy Asset Managers LLC now owns 1,822 shares of the company’s stock worth $356,000 after buying an additional 62 shares during the last quarter. Finally, Edge Capital Group LLC raised its position in shares of Zoetis by 3.7% during the 2nd quarter. Edge Capital Group LLC now owns 1,786 shares of the company’s stock valued at $310,000 after buying an additional 64 shares in the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several research analysts recently commented on the company. JPMorgan Chase & Co. lifted their price target on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. UBS Group initiated coverage on Zoetis in a research note on Monday, December 9th. They issued a “neutral” rating and a $196.00 price objective for the company. Stifel Nicolaus cut their target price on Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. Leerink Partners initiated coverage on Zoetis in a report on Monday, December 2nd. They set an “outperform” rating and a $215.00 price target on the stock. Finally, Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. One analyst has rated the stock with a hold rating, nine have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $211.89.
Zoetis Stock Performance
Shares of Zoetis stock opened at $164.31 on Wednesday. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. The stock’s fifty day moving average is $171.31 and its two-hundred day moving average is $180.16. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $200.53. The company has a market capitalization of $74.13 billion, a PE ratio of 30.89, a price-to-earnings-growth ratio of 2.91 and a beta of 0.89.
Zoetis (NYSE:ZTS – Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. The firm had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The business’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.36 earnings per share. As a group, analysts expect that Zoetis Inc. will post 5.9 earnings per share for the current year.
Zoetis Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.22%. The ex-dividend date of this dividend is Tuesday, January 21st. This is an increase from Zoetis’s previous quarterly dividend of $0.43. Zoetis’s payout ratio is currently 37.59%.
Zoetis Company Profile
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Featured Stories
- Five stocks we like better than Zoetis
- Compound Interest and Why It Matters When Investing
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.